To amend title XVIII of the Social Security Act to establish a full risk ACO program.

HR8129 establishes a full risk Accountable Care Organization (ACO) program under Medicare, fundamentally altering the reimbursement model from fee-for-service to value-based care. This means healthcare providers will be incentivized and financially responsible for patient outcomes and cost efficiency, rather than the volume of services provided. This shift is happening now and will accelerate the transition of Medicare beneficiaries into managed care models, increasing the total addressable market for entities capable of assuming and managing this financial risk. The money trail flows directly to large health insurers and healthcare technology companies. These entities possess the capital, infrastructure, and analytical capabilities required to manage population health, coordinate care, and absorb financial risk associated with patient outcomes. They will receive direct payments from Medicare based on their ability to meet quality metrics and reduce costs. Companies offering risk stratification, predictive analytics, care management platforms, and health information exchange solutions will see increased demand for their services, as providers seek tools to succeed in this new payment environment. This bill does not appropriate new funds but reallocates existing Medicare spending based on performance. Historically, the Affordable Care Act (ACA) of 2010 introduced and expanded ACO models, albeit with less emphasis on full financial risk. Following the ACA's implementation, companies like $UNH and $CVS (through Aetna) significantly expanded their Medicare Advantage and managed care offerings. While direct stock market reactions to specific ACO model expansions are difficult to isolate, the broader trend towards managed care has consistently benefited these large insurers. For example, from 2010 to 2015, $UNH's stock price increased by approximately 150% as managed care enrollment grew and the company expanded its Optum health services segment, which provides many of the data and care coordination services critical for ACO success. Specific winners include large health insurers with established risk management capabilities: UnitedHealth Group ($UNH), CVS Health ($CVS) through Aetna, Humana ($HUM), Centene ($CNC), and Elevance Health ($ELV). Healthcare technology and services companies that provide the infrastructure for risk management and care coordination will also benefit: LabCorp ($LH) and IQVIA ($IQV) for data and analytics, McKesson ($MCK) for pharmaceutical and medical supply chain management integrated with data services, and AMN Healthcare Services ($AMN) for staffing and workforce solutions in value-based care settings. There are no clear losers from this bill, as it primarily shifts existing spending and creates new opportunities for efficient providers and their partners. This bill has been referred to two committees. The next step is committee hearings and potential markups. Given the sponsorship by a Republican Representative and the bipartisan nature of value-based care initiatives, the bill has a moderate chance of advancing. If it passes, implementation would likely begin 12-18 months after enactment, providing a clear runway for companies to expand their offerings and secure new contracts.